(Q34542859)

English

Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metformin

scientific article published on November 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metformin (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

type 2 diabetes

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin therapy

1 reference

based on heuristic

inferred from title

1 reference

10.1016/S1056-8727(03)00076-X

https://api.crossref.org/works/10.1016/S1056-8727(03)00076-X

26 March 2024

internal medicine

1 reference

10.1016/S1056-8727(03)00076-X

https://api.crossref.org/works/10.1016/S1056-8727(03)00076-X

26 March 2024

author name string

Charles Kilo

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Nicholas Mezitis

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Rajeev Jain

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

James Mersey

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Janet McGill

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Philip Raskin

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14583174

26 March 2024

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S105687270300076X?httpAccept=text/xml

1 reference

10.1016/S1056-8727(03)00076-X

https://api.crossref.org/works/10.1016/S1056-8727(03)00076-X

26 March 2024

https://api.elsevier.com/content/article/PII:S105687270300076X?httpAccept=text/plain

1 reference

10.1016/S1056-8727(03)00076-X

https://api.crossref.org/works/10.1016/S1056-8727(03)00076-X

26 March 2024

Journal of Diabetes and its Complications

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

307-313

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM): an update. European NIDDM Policy Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Value of glucose control in preventing complications of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: a double-blind crossover study in adults with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined therapy for obese type 2 diabetes: suppertime mixed insulin with daytime sulfonylurea

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of insulin and metformin in the treatment of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Bedtime insulin/daytime glipizide. Effective therapy for sulfonylurea failures in NIDDM.

17

1 reference

10.1016/S1056-8727(03)00076-X

https://api.crossref.org/works/10.1016/S1056-8727(03)00076-X

26 March 2024

Identifiers

10.1016/S1056-8727(03)00076-X

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34542859&oldid=2111183537"